Lawmakers came together to fund the government on Friday, keeping the lights on in Washington until early next year and ...

When applied to colorectal cancer cells, they demonstrated through molecular and animal experiments ... KIST introduces ...

Braftovi received accelerated approval with Erbitux and mFOLFOX6 for metastatic colorectal cancer with a BRAF V600E mutation.

Mainz Biomed has announced a partnership with Quest Diagnostics to support the commercialisation of its NextGen colorectal ...

A non-invasive, easy-to-use test, like the Cologuard test, is a simple and effective way to screen for colorectal cancer. In ...